Business
Danaher Reports First Quarter 2025 Results
Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 28, 2025.
About this update from Danaher Corporation
[{"type":"text","content":"WASHINGTON, April 22, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 28, 2025.","length":172,"tagName":"p"},{"type":"text","content":"Key First Quarter 2025 Results","length":30,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net earnings were $1.0 billion, or $1.32 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $1.88.","length":137,"tagName":"p"}]},{"val":[{"type":"text","content":"Revenues decreased 1.0% to $5.7 billion and non-GAAP core revenue was flat year-over-year.","length":90,"tagName":"p"}]},{"val":[{"type":"text","content":"Operating cash flow was $1.3 billion and non-GAAP free cash flow was $1.1 billion.","length":82,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":309,"olType":false},{"type":"text","content":"Rainer M. Blair, President and Chief Executive Officer, stated, "Revenue, earnings, and cash flow exceeded our expectations in the first quarter–highlighted by continued momentum in bioprocessing and better-than-expected respiratory demand in our molecular diagnostics business. Our team also continued to execute very well, leveraging the Danaher Business System to accelerate innovation, drive share gains, and deliver meaningful productivity improvements."","length":475,"tagName":"p"},{"type":"text","content":"Blair continued, "While the macro backdrop has become more dynamic since the start of the year, it's in times like these that Danaher's positioning and capabilities truly stand out. We believe that the combination of our team's DBS-driven execution, resilient portfolio and strong balance sheet will continue to differentiate Danaher in 2025 and beyond."","length":382,"tagName":"p"},{"type":"text","content":"Second Quarter and Full Year 2025 Outlook","length":41,"tagName":"p"},{"type":"text","content":"The Company provides forecasted sales only on a non-GAAP basis because of the difficulty in estimating the other components of GAAP revenue, such as currency translation, acquisitions and divested product lines. In addition, we do not reconcile forecasted adjusted diluted net earnings per common share (or components thereof) to the comparable GAAP measure because of the difficulty in estim...